203 related articles for article (PubMed ID: 24305930)
1. Morbidity of chemotherapy administration and satisfaction in breast cancer patients: a comparative study of totally implantable venous access device (TIVAD) versus peripheral venous access usage.
Singh KR; Agarwal G; Nanda G; Chand G; Mishra A; Agarwal A; Verma AK; Mishra SK; Goyal P
World J Surg; 2014 May; 38(5):1084-92. PubMed ID: 24305930
[TBL] [Abstract][Full Text] [Related]
2. Quality-of-life assessment: arm TIVAD versus chest TIVAD.
Burbridge B; Goyal K
J Vasc Access; 2016 Nov; 17(6):527-534. PubMed ID: 27768211
[TBL] [Abstract][Full Text] [Related]
3. Which is Better for Patients with Breast Cancer: Totally Implanted Vascular Access Devices (TIVAD) or Peripherally Inserted Central Catheter (PICC)?
Tang TT; Liu L; Li CX; Li YT; Zhou T; Li HP; Wang J
World J Surg; 2019 Sep; 43(9):2245-2249. PubMed ID: 31098669
[TBL] [Abstract][Full Text] [Related]
4. Do we still need studies on the value of the TIVAD for cancer patients?
Di Carlo I; Toro A
World J Surg; 2014 Aug; 38(8):2186. PubMed ID: 24481993
[No Abstract] [Full Text] [Related]
5. Patient satisfaction and acceptance of their totally implanted central venous catheter: a French prospective multicenter study.
Marcy PY; Schiappa R; Ferrero JM; Dahlet C; Brenet O; Yazbec G; Dubois PY; Salm B; Fouche Y; Mari V; Montastruc M; Lebrec N; Ancel B; Paillocher N; Dupoiron D; Rangeard O; Gal J; Ettaiche M; Chateau Y; Chamorey E
J Vasc Access; 2017 Sep; 18(5):390-395. PubMed ID: 28731491
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of the perceptions and cosmetic satisfaction of breast cancer patients undergoing totally implantable vascular access device (TIVAD) placement.
Liberale G; El Houkayem M; Viste C; Bouazza F; Moreau M; El Nakadi I; Veys I
Support Care Cancer; 2016 Dec; 24(12):5035-5040. PubMed ID: 27495928
[TBL] [Abstract][Full Text] [Related]
7. A comparative study between two central veins for the introduction of totally implantable venous access devices in 1201 cancer patients.
Araújo C; Silva JP; Antunes P; Fernandes JM; Dias C; Pereira H; Dias T; Fougo JL
Eur J Surg Oncol; 2008 Feb; 34(2):222-6. PubMed ID: 17566692
[TBL] [Abstract][Full Text] [Related]
8. Retrospective evaluation of totally implantable venous access port devices: early and late complications.
Gurkan S; Seber S; Gur O; Yetisyigit T; Okan Donbaloglu M; Ozkaramanli Gur D
J BUON; 2015; 20(1):338-45. PubMed ID: 25778336
[TBL] [Abstract][Full Text] [Related]
9. Is there any effect of first-day usage of a totally implantable venous access device on complications?
Karanlik H; Odabas H; Yildirim I; Ozgur I; Kilic B; Sen F; Kurul S; Aydiner A
Int J Clin Oncol; 2015 Dec; 20(6):1057-62. PubMed ID: 25911604
[TBL] [Abstract][Full Text] [Related]
10. Totally implanted venous access devices implanted in the saphenous vein. Relation between the reservoir site and comfort/discomfort of the patients.
Toro A; Mannino M; Cappello G; Celeste S; Cordio S; Di Carlo I
Ann Vasc Surg; 2012 Nov; 26(8):1127.e9-1127.e13. PubMed ID: 22951064
[TBL] [Abstract][Full Text] [Related]
11. Catheter-related Complications of Subcutaneous Implantable Venous Access Devices in Breast Cancer Patients.
El-Balat A; Schmeil I; Karn T; Holtrich U; Mavrova-Risteska L; Rody A; Youssef A; Hanker LC
In Vivo; 2018; 32(5):1275-1281. PubMed ID: 30150457
[TBL] [Abstract][Full Text] [Related]
12. Introduction of a specialized consultation prior to insertion of totally implantable access venous devices: Impact on cancellation rate and patient satisfaction.
Colucci N; Gregoris A; Meyer J; Naiken SP; Staszewicz W; Gialamas E; Toso C; Abbassi Z
Vascular; 2020 Dec; 28(6):816-820. PubMed ID: 32508290
[TBL] [Abstract][Full Text] [Related]
13. [Multicenter validation study of a questionnaire assessing patient satisfaction with and acceptance of totally-implanted central venous access devices].
Marcy PY; Dahlet C; Brenet O; Yazbec G; Dubois PY; Salm B; Fouche Y; Mari V; Montastruc M; Lebrec N; Ancel B; Paillocher N; Dupoiron D; Rangeard O; Michel C; Chateau Y; Ettaiche M; Ferrero JM; Chamorey E
Bull Cancer; 2015 Apr; 102(4):301-15. PubMed ID: 25799876
[TBL] [Abstract][Full Text] [Related]
14. Totally implantable vascular access device (TIVAD) placement: a modified technique that takes post-procedure aesthetic aspects into account.
Liberale G
Support Care Cancer; 2017 Apr; 25(4):1137-1140. PubMed ID: 27888350
[TBL] [Abstract][Full Text] [Related]
15. Hypnosis as adjunct therapy to conscious sedation for venous access device implantation in breast cancer: A pilot study.
Sterkers N; Chabrol JL; De Troyer J; Bonijol D; Darmon JC; Donnez O
J Vasc Access; 2018 Jul; 19(4):382-386. PubMed ID: 29566587
[TBL] [Abstract][Full Text] [Related]
16. Patients' attitudes to totally implantable venous access port systems for gynecological or breast malignancies.
Kreis H; Loehberg CR; Lux MP; Ackermann S; Lang W; Beckmann MW; Fasching PA
Eur J Surg Oncol; 2007 Feb; 33(1):39-43. PubMed ID: 17029869
[TBL] [Abstract][Full Text] [Related]
17. Ultrasound-guided totally implantable venous access device through the right innominate vein in older patients is safe and reliable.
Sun X; Zhang Y; Yang C; Zhou Y; Bai X; Zheng W; Jin Y
Geriatr Gerontol Int; 2019 Mar; 19(3):218-221. PubMed ID: 30724007
[TBL] [Abstract][Full Text] [Related]
18. Maintaining patency in totally implantable venous access devices (TIVAD): a time-to-event analysis of different lock irrigation intervals.
Palese A; Baldassar D; Rupil A; Bonanni G; Capellari Maria T; Contessi D; De Crignis L; Vidoni A; Piller Roner S; Zanini A
Eur J Oncol Nurs; 2014 Feb; 18(1):66-71. PubMed ID: 24100090
[TBL] [Abstract][Full Text] [Related]
19. Assessing the time-to-removal of totally implantable venous access devices comparing valved-versus open-ended catheters in patients treated with chemotherapy.
Amroun K; Brugel M; Rhaiem R; Teuma L; Vannieuwenhuyse G; Lipere A; Brenet E; Kianmanesh R; Bouché O
J Vasc Access; 2024 Jan; ():11297298231223539. PubMed ID: 38205615
[TBL] [Abstract][Full Text] [Related]
20. A prospective, randomized study assessing different modalities for flushing totally implanted vascular access device in children with malignancy.
Hsieh HC; Hung SC; Huang SY; Huang FL; Chou CM
J Chin Med Assoc; 2022 Jan; 85(1):114-119. PubMed ID: 34407037
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]